Sander de Vos – CBO

Sander has a background in Molecular Biology. He co-developed a molecular diagnostic test for simultaneous detection  of  tick-borne  pathogens  and  contributed to the  development of a vaccine against ticks at the Faculty of Veterinary Medicine of the Utrecht University. His commercial career started at Westburg Life Sciences and for more than 10 years, he shaped and directed the sales strategy and commercial development of their life science business. Sander acquired experience as an entrepreneur growing a private business and led the commercial team of Isogen Lifescience. Before joining VIVOLTA, Sander worked at Mimetas, an innovative Dutch scale-up company providing novel human cell biology models for improved therapies, where he build the global commercial team and played  a key  role  in  expanding  the collaborations  with its pharma and biotech partners.